Pharma Journalist 9038 posts 0 comments

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for…
Read More...

VITRAC Therapeutics, LLC (VITRAC) initiated the global clinical development of VIC-1911, an oncology candidate formally known as TAS-119, which was licensed from Taiho Pharmaceutical…
Read More...

Biocare Medical announces a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics. Bethyl Laboratories has 45…
Read More...

SFA Therapeutics, Inc. announced that the US FDA has provided approval to conduct a clinical trial (officially referred to as an IND) for the treatment of "the appearance of the…
Read More...

Nordic Nanovector ASA announces that the US Food and Drug Administration (FDA) has granted Fast Track designation for investigating Betalutin (177Lu lilotomab satetraxetan) for the…
Read More...

GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral…
Read More...

Tiziana Life Sciences plc announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody…
Read More...

Novartis Pharma K.K. announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Tabrecta (capmatinib, formerly INC280), an oral MET inhibitor for MET exon 14…
Read More...

SMi Reports: ‘Developing custom syringes for highly viscous formulations’ one of the many topics to be presented at the inaugural Pre-filled Syringes San Francisco Conference on…
Read More...

LabCorp announced the launch of a new test that can be used to assess the capacity of antibodies in patient plasma to inhibit the SARS-CoV-2 virus. This information could be used in the…
Read More...